Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Tirzepatide (LY3298176) is a synthetic 39-amino-acid peptide studied in preclinical models as a dual agonist of the GIP and GLP-1 receptors a mechanism researchers describe as twincretin pharmacology
As a result, the FDA has recommended against the use of compounded GLP-1 medications, despite making it legal to sell them
PlexusDx's Precision Peptide Genetic Test analyzes variants in the GIPR genes, helping identify whether you may respond better to tirzepatide's dual-pathway approach before you switch
According to FDA-approved prescribing information and large-scale clinical trials, there is no established causal link between these medications and blood clot formation
US$ 20.54
US$ 29.06
US$ 23.22
US$ 25.29
